
5N Plus Announces Election of Directors Français
MONTREAL, May 8, 2025 /CNW/ - 5N Plus Inc. (TSX: VNP) ("5N+" or the "Company"), a leading global producer of specialty semiconductors and performance materials, announced that the nominees listed in its Management Information Circular dated April 1, 2025 were elected as directors of 5N Plus at its Annual General Meeting of Shareholders (the "Meeting") held earlier today. Subsequent to the Meeting, the directors re-appointed Mr. Luc Bertrand as Chairman of the Board of Directors of the Company.
Appointment of Independent Auditor
PricewaterhouseCoopers LLP, Chartered Professional Accountants, was reappointed as independent auditor of 5N Plus until the close of the next annual general meeting of Shareholders, and the directors were authorized to fix the remuneration of the auditor.
About 5N+
5N+ is a leading global producer of specialty semiconductors and performance materials. The Company's ultra‐pure materials often form the core element of its customers' products. These customers rely on 5N+'s products to enable performance and sustainability in their own products. 5N+ deploys a range of proprietary and proven technologies to develop and manufacture its products. The Company's products enable various applications in several key industries, including renewable energy, security, space, pharmaceutical, medical imaging and industrial. Headquartered in Montréal, Quebec, 5N+ operates R&D, manufacturing and commercial centers in strategically located facilities around the world including Europe, North America and Asia.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Cision Canada
an hour ago
- Cision Canada
DRI Healthcare Trust Comments on FDA Delay for KalVista Pharmaceuticals' Sebetralstat PDUFA Goal Date Due to FDA Resourcing Constraints
- FDA decision anticipated within four weeks - TORONTO, June 13, 2025 /CNW/ - DRI Healthcare Trust (TSX: (TSX: DHT.U) (the "Trust") today announced KalVista Pharmaceuticals ("KalVista") has disclosed that it has received notice from the U.S. Food and Drug Administration ("FDA") that the FDA will not meet the June 17, 2025 PDUFA goal date for the New Drug Application (NDA) for sebetralstat, due to a heavy workload and agency resourcing issues. KalVista commented that the FDA has not requested additional data or studies and has communicated to KalVista that it anticipates delivering a decision within approximately four weeks. KalVista issued its own press release with the announcement earlier today (link). About DRI Healthcare Trust The Trust is managed by DRI Capital Inc., a pioneer in global pharmaceutical royalty monetization. Since its initial public offering in 2021, the Trust has deployed more than $1.0 billion, acquiring more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. The Trust's units are listed and trade on the Toronto Stock Exchange in Canadian dollars under the symbol " and in U.S. dollars under the symbol "DHT.U". To learn more, visit or follow us on LinkedIn. SOURCE DRI Healthcare Trust


Toronto Star
2 hours ago
- Toronto Star
Canadian and U.S. stocks down after Israeli attacks on Iran, price of oil jumps
TORONTO - Canada's main stock index closed down along with U.S. markets Friday as investors turned cautious following Israeli attacks on Iranian nuclear and military targets. The attacks, which prompted Iran to fire missiles at Israel in retaliation, raised fears the conflict could escalate further and led to a spike in the price of oil. 'It's clearly a risk-off situation, and a spot where people that maybe want to take a little bit of risk off the table have the opportunity to do so,' said Dustin Reid, chief fixed income strategist at Mackenzie Investments. ARTICLE CONTINUES BELOW Oil prices leapt, and stocks fell on worries that escalating violence following Israel's attack on Iranian nuclear and military targets could damage the flow of crude around the world, along with the global economy. (AP Video / June 13, 2025) The price of oil, already rising this week, spiked over fears of supply and trade disruptions, with the August crude oil contract up US$4.65 at US$71.29 per barrel. Higher oil prices helped soften the effects of the pullback on the S&P/TSX composite index, which closed down 111.40 points at 26,504.35 but was less affected than U.S. markets, noted Reid. 'You see materials and energy, subcomponents here within the TSX doing a little bit better, and keeping the index probably, you know, outperforming versus others.' The TSX energy index was up 2.8 per cent and gold stocks moved higher as the metal also rose, helping offset losses in most other sectors including financials, telecoms and technology. In New York, the Dow Jones industrial average was down 769.83 points, or 1.8 per cent, at 42,197.79. The S&P 500 index was down 68.29 points at 5,976.97, while the Nasdaq composite was down 255.66 points at 19,406.83. A big concern for markets is that higher oil prices will put pressure on inflation, and in turn affect interest rate decisions, said Reid. ARTICLE CONTINUES BELOW ARTICLE CONTINUES BELOW 'It's not particularly constructive for the idea that central banks can cut rates any time soon.' The higher prices could also dampen consumer spending, while the wider situation also creates higher degrees of uncertainty, he said. 'It's probably not great for global sentiment, consumer sentiment,' said Reid. 'So I am a little bit concerned here that the gains that have been had over the last handful of weeks, could be somewhat at risk.' The Canadian dollar rose, trading for 73.54 cents US compared with 73.46 cents US on Thursday, thanks in part to higher oil prices, but it didn't move as much as it might have because investors fled to the U.S. dollar for safety, said Reid. 'The Canadian dollar is surprisingly flat, kind of net net today, against the U.S. dollar anyway,' he said. 'We are seeing a decent bid for the U.S. dollar on safe haven, which has not been the case particularly since early April.' ARTICLE CONTINUES BELOW ARTICLE CONTINUES BELOW The Canadian dollar wasn't helped by manufacturing sales data out Friday that showed a fall of 2.8 per cent in April, the largest monthly drop since October 2023, as the tariff dispute with the United States hit the industry. 'The organic Canadian economy is slowing, and will continue to slow, and you can see it across different spots of the economy, manufacturing clearly being one,' said Reid. The July natural gas contract was up nine cents US at US$3.58 per mmBTU. The August gold contract was up US$50.40 at US$3,452.80 an ounce and the July copper contract was down three cents US at US$4.81 a pound. This report by The Canadian Press was first published June 13, 2025. Companies in this story: (TSX:GSPTSE, TSX:CADUSD)


Cision Canada
2 hours ago
- Cision Canada
WALL FINANCIAL CORPORATION ANNOUNCES VOTING RESULTS FROM ITS ANNUAL GENERAL MEETING OF SHAREHOLDERS HELD ON JUNE 12, 2025
VANCOUVER, BC, June 13, 2025 /CNW/ - WALL FINANCIAL CORPORATION (TSX: WFC) (the "Company") announces the voting results from its annual general meeting of shareholders held on June 12, 2025 in Vancouver, British Columbia (the "AGM"). A total of 27 shareholders were represented at the meeting, being 80.4% of the Company's issued and outstanding common shares. Shareholders voted in favour of all matters brought before the AGM including setting the numbers at seven, and the appointment of auditors for the ensuing year. Detailed results of the proxy votes for the election of directors are provided below: About Wall Financial Corporation Wall Financial Corporation is a B.C. based real estate company active in the development and management of residential and commercial rental units, development and construction of residential housing for resale, and the development and management of hotel properties. SOURCE Wall Financial Corporation For further information, contact Bruno Wall, CEO and CFO, Wall Financial Corporation, 1010 Burrard Street, Vancouver, British Columbia V6Z 2R9, 604.893.7131.